3Higgins MC,Soulen MC.Multimodality approaches for control of hepatocellular carcinoma.Tech Vasc Interv Radiol,2007,10 (1):64-66.
4Lamb B,Payne H,Vincent C,et al.The role of oncologists in multidisciplinary cancer teams in the UK:an untapped resource for teamleadership ? J Eval Clin Pract,2011,17 (6):1200-1206.
5Wu P,Dugoua JJ,Eyawo O,et al.Traditional Chinese Medicines in the treatment of hepatocellular cancers:a systematic review andmeta-analysis.J Exp Clin Cancer Res,2009,28:112.
6Ye SL,Takayama T,Geschwind J,et al.Current approaches to the treatment of early hepatocellular carcinoma.Oncologist,2010,15Suppl 4:34-41.
7Meng MB,Wen QL,Cui YL,et al.Meta-analysis:traditional Chinese medicine for improving immune response in patients withunresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.Explore (NY),2011,7 (1):37-43.
8Cho WC,Chen HY.Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma:meta-analysis.Expert Opin Investig Drugs,2009,18 (5):617-635.
9Benson AB 3rd,Abrams TA,Ben-Josef E,et al.NCCN clinical practice guidelines in oncology:hepatobiliary cancers.J Natl Compr Canc Netw,2009,7 (4):350-391.
10Lamb B,Green JS,Vincent C,et al.Decision making in surgical oncology.Surg Oncol,2011,20 (3):163-168.
